Screener
Neogen NEOG Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Neogen in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The source filing: Neogen’s 10-Q, filed April 9, 2026.
- Filed
- Apr 9, 2026, 4:03 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-149599
| Line item | Nine months ended February 28, 2026 | Nine months ended February 28, 2025 |
|---|---|---|
| Share-based compensation | 10.4 | 13.0 |
| Loss on disposal of property and equipment | 1.2 | 0.1 |
| Amortization of debt issuance costs | 1.5 | 2.6 |
| Goodwill and Other asset impairment | — | 470.8 |
| Loss on refinancing and extinguishment of debt | 0.4 | — |
| Gain on sale of business | (76.4) | — |
| Other | (0.2) | (0.3) |
| Change in operating assets and liabilities: |
Item 1. Interim Condensed Consolidated Financial Statements
FAQ
- What is Neogen's impairment charges?
- Neogen (NEOG) reported impairment charges of $0 in Q4 2025.
- How has Neogen's impairment charges changed year-over-year?
- Neogen's impairment charges decreased by 100.0% year-over-year, from $2.08M to $0.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Neogen's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude